Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Apr 22;10:7099. doi: 10.1038/s41598-020-63859-y

Author Correction: A cross-sectional study to characterize local HIV-1 dynamics in Washington, DC using next-generation sequencing

Keylie M Gibson 1,, Kamwing Jair 2, Amanda D Castel 2, Matthew L Bendall 1, Brittany Wilbourn 2, Jeanne A Jordan 2, Keith A Crandall 1,3, Marcos Pérez-Losada 1,3,4; the DC Cohort Executive Committee
PMCID: PMC7174392  PMID: 32317740

Correction to: Scientific Reports 10.1038/s41598-020-58410-y, published online 06 February 2020

This Article contains errors in Table 3. In this Article, data values provided for Participant 16 are incorrect. The correct Table 3 appears below as Table 1.

Table 1.

Haplotype diversity estimates from PredictHaplo results.

Participant PR/RT int env Viral Load (copies/mL) ARV Exposure ARV Regimen Type
Number of Haplotypes Haplotype Diversity Number of Haplotypes Haplotype Diversity Number of Haplotypes Haplotype Diversity
8 NA NA 1 0 NA NA E 2 NRTI+1 ENH+1 INSTI
9 NA NA 5 0.066 11 0.038 476 E
12 1 0 4 0.727 2 0.393 77 E 2 NRTI+1 NNRTI
13 NA NA 1 0 2 0.302 N
16 3 0.33 1 0 3 0.415 E
18 NA NA 1 0 NA NA 119149 E
19 2 0.436 2 0.499 4 0.721 244 N
20 2 0.479 1 0 2 0.281 5663 E 1 NRTI+1 PI+1 ENH
23 3 0.352 2 0.484 NA NA 927 E 2 NRTI+1 ENH+1 INSTI
25 1 0 1 0 NA NA E 2 NRTI+1 ENH+1 INSTI
26 2 0.452 2 0.466 NA NA N
27 1 0 1 0 NA NA 11 E 1 PI+1 ENH
29 2 0.464 2 0.25 5 0.62 1 E 2 NRTI+1 ENH+1 INSTI
30 2 0.441 3 0.579 1 0 625 E
31 3 0.64 3 0.526 2 0.312 E 2 NRTI+1 INSTI
32 2 0.146 2 0.339 2 0.498 E 2 NRTI+1 NNRTI+1 PI+1 ENH
33 1 0 3 0.563 3 0.601 E 2 NRTI+1 ENH+1 INSTI
34 2 0.429 2 0.2 1 0 E 2 NRTI+1 INSTI
35 2 0.385 1 0 3 0.446 E 2 NRTI+1 INSTI
37 2 0.274 1 0 10 0.027 81 E
39 NA NA 1 0 NA NA E 2 NRTI+1 ENH+1 INSTI
40 2 0.494 4 0.692 3 0.623 E
42 1 0 2 0.215 2 0.445 13979 E 2 NRTI+1 ENH+1 INSTI
43 1 0 7 0.833 NA NA 343 E
45 1 0 10 0.704 NA NA E 2 NRTI+1 ENH+1 INSTI
46 2 0.153 3 0.306 2 0.5 N
47 2 0.263 2 0.42 1 0 2755 E 1 NNRTI+1 PI+1 ENH+1 INSTI
49 2 0.455 1 0 2 0.324 282 E 2 NRTI+1 ENH+1 INSTI
50 1 0 2 0.344 3 0.624 576 E 2 NRTI+1 PI+1 ENH
51 1 0 1 0 3 0.593 E 2 NRTI+1 PI+1 ENH+1 INSTI
52 2 0.439 1 0 NA NA E 2 NRTI+1 PI+1 ENH
54 3 0.583 1 0 2 0.491 412 E 2 NRTI+1 PI+1 ENH
55 1 0 1 0 2 0.384 E 1 PI+1 ENH
56 12 0.392 3 0.641 NA NA 1368 E 2 NRTI+1 ENH+1 INSTI
57 1 0 1 0 NA NA 12786 E 2 NRTI+1 ENH+1 INSTI
58 1 0 3 0.59 4 0.659 1281 E 2 NRTI+1 ENH+1 INSTI
59 3 0.572 1 0 4 0.705 581 E 2 NRTI+1 INSTI
60 2 0.487 3 0.619 4 0.716 E 2 NRTI+1 PI+1 ENH
61 2 0.27 3 0.632 4 0.679 432 E
63 3 0.612 6 0.708 1 0 57 E 2 NRTI+1 PI
64 5 0.759 3 0.576 4 0.697 E
65 2 0.492 2 0.441 3 0.186 E 2 NRTI+1 PI+1 ENH
66 1 0 2 0.49 5 0.602 32 E 2 NRTI+1 ENH+1 INSTI
67 NA NA 2 0.45 5 0.767 E 2 NRTI+1 NNRTI
68 3 0.564 5 0.736 5 0.758 E 2 NRTI+1 NNRTI
69 1 0 4 0.543 7 0.777 48 E 2 NRTI+1 PI+1 ENH
70 4 0.603 2 0.364 5 0.743 17 N
71 1 0 4 0.72 6 0.812 E 1 NRTI+1 NNRTI+1 INSTI
72 2 0.209 3 0.614 NA NA 353 E 2 NRTI+1 NNRTI
73 1 0 3 0.66 2 0.414 E 2 NRTI+1 ENH+1 INSTI
74 1 0 5 0.779 4 0.037 1 E 2 NRTI+1 ENH+1 INSTI
75 1 0 3 0.533 7 0.663 E 2 NRTI+1 PI+1 ENH
76 1 0 1 0 5 0.777 432 E 2 NRTI+1 INSTI
77 4 0.613 4 0.658 6 0.768 113 E 2 NRTI+1 PI+1 ENH+1 INSTI
78 2 0.183 3 0.608 5 0.664 113 E 2 NRTI+1 PI+1 ENH
79 1 0 1 0 2 0.396 E 2 NRTI+1 INSTI
82 1 0 NA NA NA NA N
83 2 0.467 NA NA NA NA 554 E 2 NRTI+1 NNRTI
85 2 0.351 1 0 2 0.477 183 E 2 NRTI+1 INSTI
86 2 0.433 1 0 NA NA E 2 NRTI+1 PI+1 ENH+1 INSTI
87 2 0.499 NA NA NA NA E 2 NRTI+1 ENH+1 INSTI
88 1 0 NA NA 1 0 37 N
90 3 0.534 2 0.498 3 0.54 8914 E 2 NRTI+1 PI+1 ENH+1 CCR5+1 INSTI
91 1 0 2 0.003 NA NA 117 E 2 NRTI+1 INSTI
93 2 0.446 1 0 NA NA 94 E 2 NRTI+1 ENH+1 INSTI
94 1 0 NA NA NA NA 145 E 2 NRTI+1 PI+1 ENH
97 5 0.718 2 0.455 5 0.782 E 2 NRTI+1 INSTI
99 1 0 NA NA 1 0 184 E 2 NRTI+1 ENH+1 INSTI
Avg 2 0.265 2 0.357 4 0.47

A haplotype diversity of 0 indicates no diversity because only a single haplotype was reconstructed by PredictHaplo for the sample. Amplicons that did not pass the filtering thresholds for a sample are indicated by “NA”. ARV exposure is reported at time that blood sample was taken. N: Naïve, E: Experienced, NRTI: Nucleoside reverse transcriptase inhibitors, NNRTI: Non-nucleoside reverse transcriptase inhibitors, ENH: enhancer elements, PI: Protease Inhibitor, INSTI: Integrase Strand Transfer Inhibitor, CCR5: Cysteine-Cysteine Chemokine Receptor 5.

Contributor Information

Keylie M. Gibson, Email: kmgibson@gwu.edu

the DC Cohort Executive Committee:

Thilakavathy Subramanian, Jeffery Binkley, Rob Taylor, Nabil Rayeed, Cheryl Akridge, Stacey Purinton, Jeff Naughton, Natella Rakhmanina, Larry D’Angelo, Michael Kharfen, Angela Wood, Michael Serlin, Princy Kumar, David Parenti, Alan Greenberg, Anne Monroe, Lindsey Powers Happ, Maria Jaurretche, James Peterson, Ronald D Wilcox, Sohail Rana, Michael A Horberg, Ricardo Fernández, Annick Hebou, Carl Dieffenbach, Henry Masur, Jose Bordon, Gebeyehu Teferi, Debra Benator, Maria Elena Ruiz, Deborah Goldstein, and David Hardy


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES